PosterREPRINT AN INTERACTIVE PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE FOR EARLY CANDIDATE ANALYSIS IN DRUG DISCOVERY INTRODUCTION

Similar documents
ImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

UPLC Intact MASS Analysis Application Kit

C HA R AC T E RIZ AT IO N O F INK J E T P RINT E R C A RT RIDG E INK S USING A CHEMOMETRIC APPROACH

Routine MS Detection for USP Chromatographic Methods

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

Online Reaction Monitoring of In-Process Manufacturing Samples by UPLC

Quantitation of High Resolution MS Data Using UNIFI: Acquiring and Processing Full Scan or Tof-MRM (Targeted HRMS) Datasets for Quantitative Assays

A Protocol for High-Throughput Drug Mixture Quantitation: Fast LC MS or Flow Injection Analysis MS?

Rapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies

Prep 150 LC System: Considerations for Analytical to Preparative Scaling

Peptide Isolation Using the Prep 150 LC System

Traditional Herbal Medicine Structural Elucidation using SYNAPT HDMS

PosterREPRINT COMPARISON OF PEAK PARKING VERSUS AUTOMATED FRACTION ANALYSIS OF A COMPLEX PROTEIN MIXTURE. Introduction

IN QUALITATIVE ANALYSIS,

Lirui Qiao, 1 Rob Lewis, 2 Alex Hooper, 2 James Morphet, 2 Xiaojie Tan, 1 Kate Yu 3

Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass Frontier TM

OVERVIEW INTRODUCTION. Michael O Leary, Jennifer Gough, Tanya Tollifson Waters Corporation, Milford, MA USA

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

High-Throughput Protein Quantitation Using Multiple Reaction Monitoring

A Case of Pesticide Poisoning: The Use of a Broad-Scope Tof Screening Approach in Wildlife Protection

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

A Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone

Determination of Pharmaceuticals in Environmental Samples

DEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR

Achieve confident synthesis control with the Thermo Scientific ISQ EC single quadrupole mass spectrometer

Performing Peptide Bioanalysis Using High Resolution Mass Spectrometry with Target Enhancement MRM Acquisition

Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents

Bioanalytical Chem: 4590: LC-MSMS of analgesics LC-MS Experiment Liquid Chromatography Mass Spectrometry (LC/MS)

Application Note. Author. Abstract. Pharmaceutical QA/QC. Siji Joseph Agilent Technologies, Inc. Bangalore, India

The Nanostream (Pasadena, CA) Veloce system,

Multi-Channel SFC System for Fast Chiral Method Development and Optimization

[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

Basic Principles for Purification Using Supercritical Fluid Chromatography

Rapid Quan/Qual Metabolic Stability Analysis with Online Oxidative Metabolism Synthesis

Q-TOF PREMIER DYNAMIC RANGE ENHANCEMENT AND ACCURATE MASS MEASUREMENT PERFORMANCE

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

Effects of Aqueous Sample Content and Aqueous Co-Solvent Composition on UPC 2 Separation Performance

Expediting Achiral SFC Method Development Using a Multi-Channel SFC System with MS Detection

LC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note

Rapid Screening and Analysis of Components in Nonalcoholic Drinks Application

Application Note LCMS-112 A Fully Automated Two-Step Procedure for Quality Control of Synthetic Peptides

MassHunter METLIN Metabolite PCD/PCDL Quick Start Guide

DETERMINATION OF PESTICIDES IN FOOD USING UPLC WITH POLARITY SWITCHING TANDEM QUADRUPOLE LC/MS/MS

Application Note. Edgar Naegele. Abstract

USP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC

Conformational Characterization of Calmodulin by Hydrogen Deuterium Exchange Mass Spectrometry

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

An Automated Application Template for Dissolution Studies

Stephen McDonald, Mark D. Wrona, Jeff Goshawk Waters Corporation, Milford, MA, USA INTRODUCTION

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA USA APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

MALDI-HDMS E : A Novel Data Independent Acquisition Method for the Enhanced Analysis of 2D-Gel Tryptic Peptide Digests

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

Stephen McDonald and Mark D. Wrona Waters Corporation, Milford, MA, USA INT RO DU C T ION. Batch-from-Structure Analysis WAT E R S SO LU T IONS

APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEY WORDS. Simultaneous high-throughput screening of melamine (MEL) and cyanuric acid (CYA).

Accelerating the Metabolite Identification Process Using High Resolution Q-TOF Data and Mass-MetaSite Software

Extraction of Methylmalonic Acid from Serum Using ISOLUTE. SAX Prior to LC-MS/MS Analysis

A S ENSIT IV E M E T HO D FO R T H E D E T E RM INAT IO N O F ENDO C RIN E- D IS RU P T ING COM P OUNDS IN RIV E R WAT E R BY L C / MS/MS

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Streamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System

[application note] INTRODUCTION EXPERIMENTAL. Specimens. Extraction

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

Electron Transfer Dissociation of N-linked Glycopeptides from a Recombinant mab Using SYNAPT G2-S HDMS

Supporting Information

Identification of Human Hemoglobin Protein Variants Using Electrospray Ionization-Electron Transfer Dissociation Mass Spectrometry

Application Note. David A. Weil Zoltan Timar Michael Zumwalt Edgar Naegele. Abstract

Analysis of Labeled and Non-Labeled Proteomic Data Using Progenesis QI for Proteomics

Overview. Introduction. André Schreiber AB SCIEX Concord, Ontario (Canada)

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

IDENTIFICATION OF ORGANOMETALLIC COMPOUNDS USING FIELD DESORPTION IONIZATION ON THE GCT

A Study of Stability, Robustness and Time Efficiency of a New HPLC and a New Tandem MS

Increasing Speed of UHPLC-MS Analysis Using Single-stage Orbitrap Mass Spectrometer

Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer LCMS-9030 C146-E365

Comparison of log P/D with bio-mimetic properties

Toxicity, Teratogenic and Estrogenic Effects of Bisphenol A and its Alternative. Replacements Bisphenol S, Bisphenol F and Bisphenol AF in Zebrafish.

Implementation of Methods Translation between Liquid Chromatography Instrumentation

Isotopic-Labeling and Mass Spectrometry-Based Quantitative Proteomics

Accurate Mass Analysis of Hydraulic Fracturing Waters

Assay Transfer from HPLC to UPLC for Higher Analysis Throughput

Preparative Chromatography with Improved Loadability

Analyst Software. Automatic Optimization Tutorial

Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

Finnigan LCQ Advantage MAX

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

Live Webinar : How to be more Successful with your ACQUITY QDa Detector?

High Performance Liquid Chromatography

The Role of LC MS. in Drug Discovery

Guide to Peptide Quantitation. Agilent clinical research

Clinical Toxicology. Biomass Component Extraction: The uneaten cooked plant specimen was prepared for

FORENSIC TOXICOLOGY SCREENING APPLICATION SOLUTION

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Transcription:

INTRODUCTION Full characterization of the physicochemical properties of new chemical entities (NCE s) typically takes place in pharmaceutical development laboratories. However, in an effort to minimize drug development costs, pharmaceutical companies are now pushing physicochemical screening back into the drug discovery laboratories so that unsuitable compounds fail earlier in the process. By generating retention time and quantitative data, LC/UV/MS provides a mechanism by which indicators of compounds physicochemical properties such as solubility, hydrophobicity, membrane permeability, stability, and protein binding can be modeled and screened. The large number of compounds that require screening can be analyzed by high throughput parallel LC/UV/MS methods. This technology allows the analysis of more samples in the same time, or the analysis of multiple physicochemical properties at the same time. While many compounds can be tested, large volumes of data from these parallel analyses must still be processed and reviewed. AN INTERACTIVE PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE FOR EARLY CANDIDATE ANALYSIS IN DRUG DISCOVERY Michael Jackson, Michael P. Balogh, Warren Potts, Waters Corporation, Milford, MA 01757, USA Presented at ASMS, Montréal, Canada, June 8-12, 2003 The new software application presented here, ProfileLynx Application Manager, handles sample set management, data processing and results browsing, as well as provides exporting capabilities and interactivity with other software packages to simplify physicochemical property screening. The multiple streams of acquisition data from parallel LC/UV/MS systems are integrated into an easily managed and interpreted format by ProfileLynx. PHYSICOCHEMICAL PROPERTY PROFILING Compounds were screened for their physicochemical properties using three different indicators: Chromatographic hydrophobicity index using C 18 column retention (CHI) at various ph s - The CHI relates directly to the log D of a compound, which indicates the compound s solubility and permeability Chromatographic hydrophobicity index using immobilized artificial membrane (IAM) columns (CHI IAM ) - The CHI IAM is measured on IAM columns under gradient conditions and relates to the membrane permeability of a compound Solubility

EXPERIMENTS Single Chromatographic System Electrospray Probe Waters 1525µ Binary HPLC Pump Waters 2777 Sample Manager LC Column (0 ) Waters 299 Photodiode Array Detector Splitter (0.05 ) Waters Micromass ZQ Mass Spectrometer Waters ECP System for Early Candidate Profiling MassLynx 4.0 & ProfileLynx Application Manager Experiment 1: CHI Screening Standards with known CHI values were run to determine the correlation between retention time and CHI Pharmaceutical compounds were then analyzed and their CHI values were calculated from the compounds chromatographic retention time at Experiment 2: Simulated Solubility Screening A wide set of pharmaceutical compounds were used to simulate a solubility study The analysis used a plate of standards of known concentration and then a plate of samples with varying concentrations Calibration curves were developed using the standards, and compounds were quantified to determine their "solubility"

PosterREPRINT Parallel Chromatographic System ph 2.0 LC Columns (0 ) MUX-technology Multiplexed Interface C18 Waters Micromass ZQ Mass Spectrometer C18 ph 1 C18 IAM Waters 2777 Sample Manager with 4 Injection Valves 4 Waters 1525µ Binary HPLC Pumps 4 Waters 299 Photodiode Array Detectors Splitters (0.05 ) Waters ECP System for Early Candidate Profiling MassLynx 4.0 & ProfileLynx Application Manager Experiment 1: CHI and CHIIAM Screening Experiment 2: Simulated Solubility Screening The parallel system used four independent The parallel system used four independent binary gradient pumps for simultaneous binary gradient pumps for the simultaneous compound analysis under four different analysis of four different compounds under the separation conditions same conditions, resulting in a four-fold increase Standards with known CHI and CHIIAM values were run to determine the correlation between retention time and CHI or CHIIAM Pharmaceutical compounds were then analyzed and their CHI or CHIIAM values were calculated from the chromatographic retention time CHI values were calculated based on compound retention on C18 columns at three different ph conditions (ph 2.0,, and ph 1) CHIIAM values were calculated based on compound retention under simulated physiological conditions () in sample throughput over the single chromatographic system. Calibration curves were developed using the standards, and compounds were quantified to determine their "solubility".

METHODS Columns CHI - Waters XTerra MS C 18 3.5mm 3.9x50mm CHI IAM - Regis Technologies IAM Fast-Screen Mini Column 3x10mm with Ester IAM.PC.C10/C3 packing Simulated Solubility - Waters XTerra MS C 18 3.5mm 3.9x50mm Mobile Phases CHI & CHI IAM - A: CHI ph 2.0, 0.01% v/v phosphoric acid Injection Volume - 2.0 µl MS Conditions ESI+ and ESI- 100 to 00 amu Scan time 0.3 sec Interscan delay 0.1 sec Cone voltage 30V Capillary voltage 3.0 kv Source temp 120 C Desolvation temp 300 C - A: CHI, 10 mm ammonium acetate - A: CHI ph 1, 10 mm ammonium acetate - A: CHI IAM,, 10 mm ammonium acetate - B: ACN Simulated Solubility - A: H 2 O - B: ACN HPLC Gradients CHI and CHI IAM Simulated Stability Time 0 10 12 14 Flow %A %B Curve - 1 Time 0 4 Flow ml /min ml /min ml /min %A %B Curve -

PosterREPRINT PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE Step 2: Define and set experimental criteria for physicochemical property calibration Step 1: Define the physicochemical property experiment Sample List Using the MassLynx sample list, the physicochemical experiment parameters can be associated with appropriate samples. From the Sample List, all of the ProfileLynx Application Manager tools can be accessed. Calibration Editor Developing the relationship between retention times and physicochemical property indicators is easily enabled through the Calibration Editor in ProfileLynx. In the Calibration Editor the user simply selects the type of retention time calibration to be used (CHI, CHIIAM, IAM, or Protein Binding) and then provides a customizable name for the specific experiment. The user then sets criteria such as the equation to use for calculating the physicochemical property indicator, integration parameters, and retention time ranges for the retention time calibration.

PosterREPRINT Step 3: Review physicochemical property calibration Step 5: Review physicochemical property analysis results by compound or experiment Data Review Tool Retention time calibration review is facilitated Data Review By Compound through the Calibration Review Tool. Chromatograms can be manually integrated, peaks can be reassigned, and points can be ignored. The calibration is then stored and can be used during compound analysis. Step 4: Select the type of experiment to be run and set pass/fail criteria Data Review By Experiment Processed analysis results can be viewed by experiment or by compound using the data review tool. The sample table shows the calculated Experiment Editor physicochemical property indicator values for the samples, as well as markings to indicate whether The type of physicochemical property screening the sample passed or failed the test based on experiment to be run is selected in the Experiment threshold criteria. The first column in the display Editor. Options include CHI, IAM, solubility, shows a summary of all the pass/fail criteria. If permeability, stability, protein binding, the mouse indicator is passed over a failed field, a partitioning, and metabolic inhibition. pop-up box indicates the reason for the failure. Manual adjustments to peak integration and peak assignments may also be made in this view. Physicochemical property analysis results may also be sorted and viewed by experiment.

Step : Export data CONCLUSIONS The ProfileLynx Application Manager is well suited to do multiple physicochemical property indicator measurements simultaneously. The ProfileLynx Application Manager easily interfaces with existing data systems and can report physicochemical data using a graphical interface. The ProfileLynx Application Manager allows easy data management and review and allows full automation of physicochemical indicator measurements with little or no operator intervention. Data Export Manager Data export is facilitated through the Data Export Manager. The format of the exported data file is defined in the data review window. The export file itself can be either xml, comma delimited, tab delimited or html format. REFERENCES Valko, K.; Du, C. M.; Bevan, C. D.; Reynolds, D. P.; Abraham, M. H. J. Pharm. Sci. 2000, 89 (8), 1085-109. Valko, K.; Du, C. M.; Bevan, C. D.; Reynolds, D. P.; Abraham, M. H. Current Medicinal Chemistry. 2001, 8(7). Kangas, H.; Kotiaho, T.; Salminen, T.; Kostianinen, R. Rapid Communications in Mass Spectrometry. 2001, 15: 1501-1505. Liu, H.; Carter, G. T.; Tischler, M. Rapic Communications in Mass Spectrometry. 2001, 15: 1533-1538. Camurri, Giulio; Zaramella, Alessio. Anal. Chem. 2001, 73 (15), 371-3722. FUTURE WORK Open Access walk-up type analysis for fully automated analysis with automated reporting and e-mailing of results to chemists. Inclusion of time-based metabolic and stability calculations. Integration of a fully customizable sample import tool to allow connection with any type of sample list format. Development of database interactivity tools to allow warehousing and retrieval of the physicochemical data. ACKNOWLEDGEMENTS Andy Organ, Klara Valko; GlaxoSmithKline, UK Mark Hemling, H. Y. Cheng; GlaxoSmithKline, US Larry Mallis, Chris Petucci; Wyeth Ayerst, US Graeme Wells, Paul Chilvers, Maqsood Adia, David Deans; Waters, UK WATERS CORPORATION 34 Maple St. Milford, MA 01757 U.S.A. T: 508 478 2000 F: 508 872 1990 www.waters.com Waters, Micromass, ProfileLynx, ZQ, MassLynx, ECP, MUX-technology and XTerra are trademarks of Waters Corporation. All other trademarks are the property of their respective owners. 2003 Waters Corporation Produced in the U.S.A. June 2003 7200009EN LW-PDF